|1.||Korotkova, Marina: 1 article (04/2014)|
|2.||Jakobsson, Per-Johan: 1 article (04/2014)|
|3.||Kurahashi, Kazuyoshi: 1 article (11/2013)|
|4.||Wang, Aimin: 1 article (11/2013)|
|5.||Trandafir, Cristina C: 1 article (11/2013)|
|6.||Ji, Xu: 1 article (11/2013)|
|7.||Paul, Arun George: 1 article (06/2013)|
|8.||Chandran, Bala: 1 article (06/2013)|
|9.||Sharma-Walia, Neelam: 1 article (06/2013)|
|10.||Greene, Emily R: 1 article (11/2011)|
06/29/2007 - "Taken together, these studies identify novel eicosanoid receptor signaling pathways that mediate neuronal protection in excitotoxic paradigms; these data also support the emerging hypothesis that the toxic/protective effects of eicosanoid signaling on neuronal viability diverge significantly depending on whether excitotoxicity or inflammation predominates as the underlying toxic stimulus."
01/01/2006 - "Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis."
11/01/2011 - "Novel experimental approaches that demonstrate the anti-tumor effects of inhibiting cancer-associated inflammation currently include: eicosanoid receptor antagonism, overexpression of eicosanoid metabolizing enzymes, and the use of endogenous anti-inflammatory lipid mediators. "
04/01/2014 - "Several enzymes of the arachidonic acid cascade as well as eicosanoid receptors (all part of the eicosanoid pathway) are today well-recognized targets for anti-inflammatory drugs that can reduce symptoms of inflammation in rheumatic diseases. "
|2.||Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
|3.||Osteosarcoma (Osteogenic Sarcoma)
|4.||Rheumatic Diseases (Rheumatism)
|3.||Prostaglandin H2 Thromboxane A2 Receptors
|4.||Arachidonic Acid (Vitamin F)
|6.||Cyclic AMP (AMP, Cyclic)